Effect of probiotic strains, L-arginine and carvedilol on myocardial infarction size in systemic inflammation in rats

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Experiments revealed probiotics and L-arginine reduced myocardial infarction size in rats with systemic inflammation, suggesting potential therapies.

Probiotics and L-arginine reduced myocardial infarction size significantly compared to systemic inflammation alone, confirming cardioprotective effects.
The myocardial necrosis size in SIRS-treated rats was 45%, while it was only 32% in the probiotic group, highlighting treatment efficacy.
Analysis involved administering treatments to rat models under systemic inflammation during induced ischemic injury to assess cardioprotective outcomes.
Findings indicate probiotics and L-arginine have anti-inflammatory effects, while carvedilol showed no significant reduction in necrosis size.

Borshchev et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Experiments revealed probiotics and L-arginine reduced myocardial infarction size in rats with systemic inflammation, suggesting potential therapies.